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1. Introduction 
Sensory neuropathy is not common in prion diseases and autonomic failure has not been 
reported to be the initial or the main symptom of prion disease.(1) Here we report a 
unique familial prion disease with a novel prion gene mutationラpan-autonomicfailureラ
sensory neuropathy and mild cognitive impairment as the initial symptom. 
2. Case report 
A 34-year-old Japanese female began to have urinary retention of up to 2L at the age of 
26 years. At age 30ラshedeveloped syncope for 5 min due to orthostatic hypotension. At 
age 31ラshebegan to show memory disturbances. After the age of 31ラshesuffered from 
frequent vomiting and diarrhea. 
Her family tree is shown in Fig. la. Her mother developed dementiaラurinarydisturbance 
and orthostatic hypotension (from 140/100 mmHg lying to 80/45 standing) with 
frequent syncope attacks at the age of 47 years. She had thermoanesthesia in her lower 
limbs. One year after onsetラ shedied without a final diagnosis. The grandfather of the 
present case is told to have developed dementia with urinary disturbance and orthostatic 
hypotentisin at the age of 52 years and died at the age of 62 yearsラbutno medical record 
could be obtained. 
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The present case had a height of 159.5 cm and a body weight of 39.5 kg. Her cognitive 
function showed mild decline to 27/30 in mini-mental state examination (MMSE) and 
21/30 in Montreal cognitive assessment (MoCA). The muscles in her distal limbs were 
slightly atrophicラ andsevere thermoanesthesia and hypoalgesia were present. Her 
tendon reflexes showed generalized areflexia. Severe orthostatic hypotension was 
observed from 115/80 mmHg (lying) to 59/35 (standing). 
Cerebrospinal flood (CSF) analysis showed an elevated protein level of 141 mg/dlラand
otherwise normal data. Other laboratory data is shown in Table 1 and Fig lb-e. 
Compound muscle action potentials and sensory action potentials were not evoked in 
bilateral tibial and sural nervesラrespectively.Sural nerve biopsy revealed moderate loss 
of myelinated fibers (Fig. lf) with no deposits of amyloid material. Unlike normal sural 
nerve (Fig. lg）ラ prionprotein staining of the biopsy revealed ragged deposits in myelin 
(Fig. lhi). The serum and CSF neuron-specific enolase (NSE) levels were elevated at 
concentrations of 35.2 ng/ml and 134.9 ng/mlラrespectively.The CSF levels of 14-3-3 
and tau proteins were also elevated at 1, 125 μg/ml and 2ラ994pg/mlラrespectively.Thusラ
the prion gene was analyzedラrevealinga 2 bp deletion (CT) in codon 178 that causes 
additional variable 25 amino acid at C-terminal from the mutation site to the premature 
stop codon at codon 195 (Fig. lj). We examined this mutation by PCR-based restriction 
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fragment length polymorphism (RFLP) analysis using BssSI restriction enzyme.(2) The 
BssSI restriction site detects mutation of the present 2 bp deletion (Fig. lk). 
There are no brain autopsy data to confirm prion disease in the probandラthereforeshe 
was treated as presumed prion disease. Bi-level positive ai阿 aypressure (BiPAP) was 
initiated for her in order to avoid the sudden death at nightラandthe patient is living by 
herself today. 
3. Discussion 
We experienced the first case with severe pan-autonomic failureラ sensoryneuropathyラ
and mild cognitive impairment owing to a novel prion gene mutation. An initial 
symptom of autonomic failure of has not been reported in prion disease. Hereditary 
sensory and autonomic neuropathies (HSANs) are inherited peripheral 
neuropathies.(3) HSAN-1 is characterized by a slowly progressive loss of pain and 
temperature sensation with autosomal dominant inheritance. Causative mutations of 
HSAN-1 identified to date occur in five genes.(4ラ 5)On the other handラ otherHSAN 
subtypes are autosomal recessive diseases. Cellular prion protein is expressed in axons 
and Schwann cells of peripheral nerves; thus I 08 German HSAN patients were 
surveyed to determine whether a mutation in prion protein was responsible. However.ラ
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no prion protein mutation was found.(6) Thusラthepresent case may be classified as a 
new type ofHSAN-1 with autosomal dominant inheritance and adulthood onset. 
20 years disparity in the age of onset and protracted course in the proband are 
mysterious but difficult to explain because both her mother and grandfather died today. 
Scrapie-infected transgenic mice expressing prion protein lacking the 
glycosylphosphatidylinositol (GPI) membrane anchorラ abnormalprotease-resistant 
PrPres was reported deposited as amyloid plaquesラ ratherthan the usual nonamyloid 
form of PrPres and the mutation of the proband is likely producing anchorless PrP 
protein.(7) This present case provides important clues to the mechanisms underlying 
prion disease. 
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Figure legend 
a) Family tree showing the proband (arrow) and her mother and grandfather suffering 
from the same disease. 
b) DWI孔1Rimage showing neither cerebral atrophy nor abnormal signal intensities. 
c) 99mTc-ECD SPECT showing a decrease in cerebral blood flow in the right parietal 
and bilateral occipital lobes in eZIS analysis. 
d) Before the sweating testラherbody temperature was 36.5。C
e) At 3 5 min after the sweating testラ herbody temperature became 37.6。Cラ butshe 
showed no sweating response. 
。The peripheral nerve biopsy was taken from the left sural nerve. 
Glutaraldehyde-osmium fixed and Epon embedded semithin cross-sections were 
stained with toluidine blue and were subjected to light microscopic examination. 
Sural nerve biopsy showing moderate loss of myelinated fibers with toluidine blue 
staining. 
g) Normal sural nerve stained with an antibody for prion protein showing myelin 
staining. The biopsy specimen was fixed in I 0% formalinラandembedded in paraffin. 
For immunohistochemistryラ 4.5-μmsections were incubated in 0.3% H202 for 30 
min to bleach endogenous peroxidase activityラ andthen treated by "hydrolytic 
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autoclaving" to enhance the immunoreactivity of prion protein. Slides were 
incubated at 4 °C overnight with anti-prion protein antibody (clone 3F4ラ孔1illiporeラ
Temeculaラ CA) diluted at I :500. Positive staining was visualized by the 
avidin-biotin-peroxidase complex method with diaminobenzidine as the chromogen. 
h) Prion protein staining of the sural nerve biopsy from the proband at low 
magnification. 
i) Prion protein staining of the sural nerve biopsy from the proband showing a ragged 
depositions (arrowheads) in myelin around residual axons at high magnification. 
j) Direct PCR sequencing of the prion gene of the proband showing the 2-bp CT 
deletion. Forward sequence is upper and reverse sequence is lower. It showing 
mutation site at codon 195. 
k) PCR-RFLP analysis with the restriction enzyme BssSI, showing only 567-bp PCR 
products in normal controls I and 2ラ but567 and 280 bands in the proband with 
BssSI digestion (upper). The BssSI restriction site detects mutation of the present 
2-bp deletion (lower). 
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Table1 Comparison of this present case and her mother 
 Present patient Her mother 
Onset (year) 26 48 
Progress living death in 49 
MMSE 27 21 






Urinary retention 2000ml 300ml 
Sweating test general anhidrosis general anhidrosis 
CVRR ( CV% ) 1.01 0.98 
brain MRI no specific finding mild atrophy in parietal lobe 
SPECT 
Decrease of cerebral blood 
flow in the right parietal and 
bilateral occipital lobes 
n.e. 
CSF 14-3-3 protein 
(μg/mL) 
1,125 (+) 
CSF tau protein 
(pg/mL) 
2994 n.e. 
prion gene analysis 2bp deletion n.e. 
 
MMSE: mini-mental state examination 
FAB: Frontal assessment battery 
OH: Orthostatic hypotension 
CVRR: The coefficient of variation for R-R interval 
MRI: magnetic resonance image 
SPECT: Single photon emission computed tomography 
CSF: Cerebrospinal fluid 
 
